{"transactions":[{"id":746649,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Stock)","published_at":"2026-06-09T01:07:51.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026."}],"balance_after":16077,"derivative":{"exercise_price":15.7,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":16077},"source":{"system":"sec-edgar","filing":"0001104659-26-071507","document":"tm2617191-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465926071507/tm2617191-2_4seq1.xml","form_type":"4"}},{"id":746648,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T01:07:51.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":10350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis."}],"balance_after":61625,"source":{"system":"sec-edgar","filing":"0001104659-26-071507","document":"tm2617191-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465926071507/tm2617191-2_4seq1.xml","form_type":"4"}},{"id":808072,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. The Class A Common Stock into which such vested RSUs converted on April 13, 2026 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":808071,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1182,"price":1.28,"value":1512.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2026."}],"balance_after":2853553,"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":808070,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-04-15T20:30:22.000Z","date":"2026-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2026. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":2854735,"source":{"system":"sec-edgar","filing":"0001493152-26-016832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315226016832/ownership.xml","form_type":"4"}},{"id":1041874,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T21:30:14.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the options vested on the 25th of each month for forty-eight months beginning on 9/25/2015."}],"balance_after":0,"derivative":{"exercise_price":2.66,"expiration_date":"2025-09-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-25-089633","document":"tm2526007-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925089633/tm2526007-1_4seq1.xml","form_type":"4"}},{"id":1041873,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T21:30:14.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":9.7095,"value":242737.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.8609, inclusive."}],"balance_after":51275,"source":{"system":"sec-edgar","filing":"0001104659-25-089633","document":"tm2526007-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925089633/tm2526007-1_4seq1.xml","form_type":"4"}},{"id":1041872,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T21:30:14.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":2.66,"value":133000.0,"ownership":{"direct":true},"balance_after":76275,"source":{"system":"sec-edgar","filing":"0001104659-25-089633","document":"tm2526007-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925089633/tm2526007-1_4seq1.xml","form_type":"4"}},{"id":1053058,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T22:46:12.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":8.6,"value":43000.0,"ownership":{"direct":true},"balance_after":26275,"source":{"system":"sec-edgar","filing":"0001104659-25-085826","document":"tm2524813-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925085826/tm2524813-1_4seq1.xml","form_type":"4"}},{"id":1116699,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Stock)","published_at":"2025-06-10T23:24:23.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":41098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the options vest on the 6th of the month for twelve months beginning July 6, 2025."}],"balance_after":41098,"derivative":{"exercise_price":7,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":41098},"source":{"system":"sec-edgar","filing":"0001104659-25-058267","document":"tm2517578-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925058267/tm2517578-2_4seq1.xml","form_type":"4"}},{"id":1116698,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-10T23:24:23.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":23214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on June 6, 2026, and upon vesting automatically convert to shares of common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on June 6, 2026, and upon vesting automatically convert to shares of common stock on a one-for-one basis."}],"balance_after":31275,"source":{"system":"sec-edgar","filing":"0001104659-25-058267","document":"tm2517578-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925058267/tm2517578-2_4seq1.xml","form_type":"4"}},{"id":1122486,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":3281,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1122485,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":1.64,"value":1892.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":2851454,"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1122484,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-04T20:30:33.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":2852608,"source":{"system":"sec-edgar","filing":"0001641172-25-013629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225013629/ownership.xml","form_type":"4/A","original_submission_date":"2025-04-15"}},{"id":1129606,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T23:00:17.000Z","date":"2025-05-28","kind":"sale","planned":false,"acquired":false,"shares":12500,"price":6.1,"value":76250.0,"ownership":{"direct":true},"balance_after":8061,"source":{"system":"sec-edgar","filing":"0001104659-25-055047","document":"tm2516629-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465925055047/tm2516629-1_4seq1.xml","form_type":"4"}},{"id":1171638,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4."}],"balance_after":3281,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1171637,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":1.64,"value":1892.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025."}],"balance_after":20328,"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1171636,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-15T20:30:27.000Z","date":"2025-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022."}],"balance_after":21482,"source":{"system":"sec-edgar","filing":"0001641172-25-004823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000164117225004823/ownership.xml","form_type":"4"}},{"id":1307629,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:06:54.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":21815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026."}],"balance_after":21815,"derivative":{"exercise_price":1.9,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":21815},"source":{"system":"sec-edgar","filing":"0001520138-25-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013825000016/ownership.xml","form_type":"4"}},{"id":1307628,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:06:54.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":49800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting."}],"balance_after":49800,"derivative":{"exercise_price":3.36,"expiration_date":"2029-11-20","underlying":"Common Stock","underlying_shares":49800},"source":{"system":"sec-edgar","filing":"0001520138-25-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013825000016/ownership.xml","form_type":"4"}},{"id":1347514,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T00:00:11.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":6.48,"value":16200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.40 to $6.60, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20561,"source":{"system":"sec-edgar","filing":"0001104659-24-124748","document":"tm2429945-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924124748/tm2429945-1_4seq1.xml","form_type":"4"}},{"id":1423479,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T23:11:23.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":9.465,"value":9465.0,"ownership":{"direct":true},"balance_after":23061,"source":{"system":"sec-edgar","filing":"0001104659-24-092969","document":"tm2422715-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924092969/tm2422715-1_4seq1.xml","form_type":"4"}},{"id":1428003,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T21:28:55.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":9,"value":9000.0,"ownership":{"direct":true},"balance_after":23561,"source":{"system":"sec-edgar","filing":"0001104659-24-091339","document":"tm2422188-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924091339/tm2422188-1_4seq1.xml","form_type":"4"}},{"id":1428002,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-20T21:28:55.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":8.3954,"value":8395.4,"ownership":{"direct":true},"balance_after":24561,"source":{"system":"sec-edgar","filing":"0001104659-24-091339","document":"tm2422188-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924091339/tm2422188-1_4seq1.xml","form_type":"4"}},{"id":1507507,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Stock)","published_at":"2024-05-21T23:01:49.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":23830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the options vest on the 17th of the month for twelve months beginning June 17, 2024."}],"balance_after":23830,"derivative":{"exercise_price":12.65,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":23830},"source":{"system":"sec-edgar","filing":"0001104659-24-063964","document":"tm2415098-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924063964/tm2415098-3_4seq1.xml","form_type":"4"}},{"id":1507506,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T23:01:49.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":12845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on May 17, 2025, and upon vesting automatically convert to shares of common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on May 17, 2025, and upon vesting automatically convert to shares of common stock on a one-for-one basis."}],"balance_after":25561,"source":{"system":"sec-edgar","filing":"0001104659-24-063964","document":"tm2415098-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465924063964/tm2415098-3_4seq1.xml","form_type":"4"}},{"id":1541005,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-17T00:56:09.000Z","date":"2024-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1154,"price":4.11,"value":4742.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\") and does not represent a sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,688 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On February 29, 2024, the Issuer effected a 1-for-10 reverse stock split (the \"Reverse Stock Split\") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":2855889,"source":{"system":"sec-edgar","filing":"0001493152-24-014947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315224014947/ownership.xml","form_type":"4"}},{"id":1628330,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2024-02-22T02:46:31.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":2937788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":2937788,"derivative":{"exercise_price":0.434,"expiration_date":"2034-02-15","underlying":"Class A Common Stock","underlying_shares":2937788},"source":{"system":"sec-edgar","filing":"0001493152-24-007491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000149315224007491/ownership.xml","form_type":"4"}},{"id":1707763,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-19T00:19:00.000Z","date":"2023-12-14","kind":"sale","planned":false,"acquired":false,"shares":800,"price":16.89,"value":13512.0,"ownership":{"direct":true},"balance_after":12716,"source":{"system":"sec-edgar","filing":"0001104659-23-127005","document":"tm2333196-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465923127005/tm2333196-1_4seq1.xml","form_type":"4"}},{"id":1712932,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T23:02:05.000Z","date":"2023-12-11","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":15.5,"value":15500.0,"ownership":{"direct":true},"balance_after":13516,"source":{"system":"sec-edgar","filing":"0001104659-23-125791","document":"tm2332860-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465923125791/tm2332860-1_4seq1.xml","form_type":"4"}},{"id":1719851,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-06T21:15:42.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":42254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting."}],"balance_after":42254,"source":{"system":"sec-edgar","filing":"0001520138-23-000532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013823000532/ownership.xml","form_type":"4"}},{"id":1762400,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-11T01:48:11.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":3050427,"price":0.1586,"value":483797.7222,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, the Reporting Person and Sorrento Therapeutics, Inc. (\"Sorrento\"), which is in voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the \"Bankruptcy Court\"), entered into a Stock Purchase Agreement (the \"SPA\") pursuant to which the Reporting Person agreed (i) to acquire on the date of the signing of the SPA, 9,064,539 shares of the Issuer's Class A common stock for an aggregate amount in cash equal to $1.5 million, payable on such initial closing date, and (ii) to acquire, no later than October 4, 2023, the remaining 11,357,585 shares of the Issuer's Class A common stock owned by Sorrento for an aggregate amount in cash equal to 75% of the 5-Day VWAP of the Issuer's Class A common stock calculated as provided in the SPA."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1): The Reporting Person received 9,064,539 shares of the Issuer's Class A common stock on October 4, 2023. The Reporting Person received 6,307,158 shares of the Issuer's Class A common stock on October 6, 2023.  The Reporting Person received the remaining 3,050,427 shares of the Issuer's Class A common stock on October 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 98,426 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."}],"balance_after":28570434,"source":{"system":"sec-edgar","filing":"0000950170-23-052758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000095017023052758/ownership.xml","form_type":"4"}},{"id":1762399,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-11T01:48:11.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":6307158,"price":0.1586,"value":1000315.2588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, the Reporting Person and Sorrento Therapeutics, Inc. (\"Sorrento\"), which is in voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the \"Bankruptcy Court\"), entered into a Stock Purchase Agreement (the \"SPA\") pursuant to which the Reporting Person agreed (i) to acquire on the date of the signing of the SPA, 9,064,539 shares of the Issuer's Class A common stock for an aggregate amount in cash equal to $1.5 million, payable on such initial closing date, and (ii) to acquire, no later than October 4, 2023, the remaining 11,357,585 shares of the Issuer's Class A common stock owned by Sorrento for an aggregate amount in cash equal to 75% of the 5-Day VWAP of the Issuer's Class A common stock calculated as provided in the SPA."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1): The Reporting Person received 9,064,539 shares of the Issuer's Class A common stock on October 4, 2023. The Reporting Person received 6,307,158 shares of the Issuer's Class A common stock on October 6, 2023.  The Reporting Person received the remaining 3,050,427 shares of the Issuer's Class A common stock on October 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 98,426 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."}],"balance_after":25520007,"source":{"system":"sec-edgar","filing":"0000950170-23-052758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000095017023052758/ownership.xml","form_type":"4"}},{"id":1762398,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-11T01:48:11.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":9064539,"price":0.1655,"value":1500181.2045,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 29, 2023, the Reporting Person and Sorrento Therapeutics, Inc. (\"Sorrento\"), which is in voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the \"Bankruptcy Court\"), entered into a Stock Purchase Agreement (the \"SPA\") pursuant to which the Reporting Person agreed (i) to acquire on the date of the signing of the SPA, 9,064,539 shares of the Issuer's Class A common stock for an aggregate amount in cash equal to $1.5 million, payable on such initial closing date, and (ii) to acquire, no later than October 4, 2023, the remaining 11,357,585 shares of the Issuer's Class A common stock owned by Sorrento for an aggregate amount in cash equal to 75% of the 5-Day VWAP of the Issuer's Class A common stock calculated as provided in the SPA."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1): The Reporting Person received 9,064,539 shares of the Issuer's Class A common stock on October 4, 2023. The Reporting Person received 6,307,158 shares of the Issuer's Class A common stock on October 6, 2023.  The Reporting Person received the remaining 3,050,427 shares of the Issuer's Class A common stock on October 10, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 98,426 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."}],"balance_after":19212849,"source":{"system":"sec-edgar","filing":"0000950170-23-052758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000095017023052758/ownership.xml","form_type":"4"}},{"id":1783276,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-12T22:01:31.000Z","date":"2023-09-06","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":13.6,"value":20400.0,"ownership":{"direct":true},"balance_after":14516,"source":{"system":"sec-edgar","filing":"0001104659-23-100116","document":"tm2325917d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465923100116/tm2325917d1_4seq1.xml","form_type":"4"}},{"id":1891912,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Stock)","published_at":"2023-05-16T23:27:51.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":15125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023."}],"balance_after":15125,"derivative":{"exercise_price":20.05,"expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":15125},"source":{"system":"sec-edgar","filing":"0001104659-23-061520","document":"tm2316016-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465923061520/tm2316016-3_4seq1.xml","form_type":"4"}},{"id":1891911,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T23:27:51.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":8105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis."}],"balance_after":16016,"source":{"system":"sec-edgar","filing":"0001104659-23-061520","document":"tm2316016-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465923061520/tm2316016-3_4seq1.xml","form_type":"4"}},{"id":1918879,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-04-18T01:19:35.000Z","date":"2023-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":11540,"price":0.7141,"value":8240.714,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\") and does not represent a sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 98,426 shares underlying RSUs subject to vesting. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.   ."}],"balance_after":10148310,"source":{"system":"sec-edgar","filing":"0000899243-23-011343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924323011343/doc4.xml","form_type":"4"}},{"id":1937713,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (Right to Buy)","published_at":"2023-03-28T00:27:51.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":false,"shares":2084854,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023."}],"balance_after":2084854,"derivative":{"exercise_price":3,"expiration_date":"2028-03-27","underlying":"Class A Common Stock","underlying_shares":2084854},"source":{"system":"sec-edgar","filing":"0000950170-23-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000095017023010087/ownership.xml","form_type":"4"}},{"id":1937712,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-28T00:27:51.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":2084854,"price":0.8343,"value":1739393.6922,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 27, 2023, the Reporting Person purchased directly from the Issuer (i) 2,084,854 shares of the Issuer's Class A common stock at a price of $0.8343 per share, and (ii) a 5-year immediately exercisable warrant to purchase 2,084,854 shares of the Issuer's Class A common stock at an exercise price of $3.00, at a price of $0.125 per whole share underlying the warrant, or an aggregate purchase price of $2.0 million pursuant to a securities purchase agreement dated March 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes 131,234 shares underlying restricted stock units subject to vesting."}],"balance_after":10159850,"source":{"system":"sec-edgar","filing":"0000950170-23-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000095017023010087/ownership.xml","form_type":"4"}},{"id":2052129,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-01-18T21:24:01.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":34240,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34240,"source":{"system":"sec-edgar","filing":"0001520138-23-000057","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013823000057/ownership.xml","form_type":"4"}},{"id":2101265,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-01T00:55:15.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":10000,"price":1.7175,"value":17175.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.715 to $1.7199, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8074996,"source":{"system":"sec-edgar","filing":"0000899243-22-037241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322037241/doc4.xml","form_type":"4"}},{"id":2102203,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-30T00:53:04.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":40000,"price":1.71,"value":68400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.655 to $1.7799, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8064996,"source":{"system":"sec-edgar","filing":"0000899243-22-037162","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322037162/doc4.xml","form_type":"4"}},{"id":2103190,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-29T00:13:52.000Z","date":"2022-11-28","kind":"purchase","acquired":true,"shares":40000,"price":1.74,"value":69600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.8498, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8024996,"source":{"system":"sec-edgar","filing":"0000899243-22-037102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322037102/doc4.xml","form_type":"4"}},{"id":2173755,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-26T01:14:26.000Z","date":"2022-08-24","kind":"exercise","acquired":false,"shares":119073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and exercisable."}],"balance_after":230287,"derivative":{"exercise_price":2.87,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":119073},"source":{"system":"sec-edgar","filing":"0000899243-22-029784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322029784/doc4.xml","form_type":"4"}},{"id":2173754,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-26T01:14:26.000Z","date":"2022-08-24","kind":"exercise","acquired":true,"shares":119073,"price":2.87,"value":341739.51,"ownership":{"direct":true},"balance_after":7984996,"source":{"system":"sec-edgar","filing":"0000899243-22-029784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322029784/doc4.xml","form_type":"4"}},{"id":2184653,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-16T22:27:47.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":2000,"price":43.2907,"value":86581.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.26 to $43.325, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7911,"source":{"system":"sec-edgar","filing":"0001104659-22-091871","document":"tm2223624-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922091871/tm2223624-1_4seq1.xml","form_type":"4"}},{"id":2284745,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Stock)","published_at":"2022-05-04T00:01:43.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":13981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022."}],"balance_after":13981,"derivative":{"exercise_price":22.56,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":13981},"source":{"system":"sec-edgar","filing":"0001104659-22-055438","document":"tm2214402-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922055438/tm2214402-3_4seq1.xml","form_type":"4"}},{"id":2284744,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Rights","published_at":"2022-05-04T00:01:43.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":2708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2022-04-30","underlying":"Common Stock","underlying_shares":2708},"source":{"system":"sec-edgar","filing":"0001104659-22-055438","document":"tm2214402-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922055438/tm2214402-3_4seq1.xml","form_type":"4"}},{"id":2284743,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T00:01:43.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":2708,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date."}],"balance_after":9911,"source":{"system":"sec-edgar","filing":"0001104659-22-055438","document":"tm2214402-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922055438/tm2214402-3_4seq1.xml","form_type":"4"}},{"id":2284742,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-04T00:01:43.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":7203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis."}],"balance_after":7203,"source":{"system":"sec-edgar","filing":"0001104659-22-055438","document":"tm2214402-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465922055438/tm2214402-3_4seq1.xml","form_type":"4"}},{"id":2288610,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-29T01:05:45.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":384801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":384801,"derivative":{"exercise_price":10.16,"expiration_date":"2032-04-13","underlying":"Class A Common Stock","underlying_shares":384801},"source":{"system":"sec-edgar","filing":"0000899243-22-015912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322015912/doc4.xml","form_type":"4"}},{"id":2288609,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-29T01:05:45.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":131234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock.  The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":7865923,"source":{"system":"sec-edgar","filing":"0000899243-22-015912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000089924322015912/doc4.xml","form_type":"4"}},{"id":2293561,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-20T20:46:44.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":122250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted pursuant to the Company???s 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were 25% vested upon grant, with the remaining 75% vesting ratably over a three-year period on each anniversary of the grant date."}],"balance_after":122250,"derivative":{"exercise_price":5.04,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":122250},"source":{"system":"sec-edgar","filing":"0001062993-22-010536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000106299322010536/form4.xml","form_type":"4"}},{"id":2557370,"issuer":{"id":7702,"kind":"organization","name":"BIOVIE INC."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-28T20:25:50.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":95900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant."}],"balance_after":95900,"derivative":{"exercise_price":13.91,"expiration_date":"2025-12-18","underlying":"Common Stock","underlying_shares":95900},"source":{"system":"sec-edgar","filing":"0001520138-21-000583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000152013821000583/ownership.xml","form_type":"4"}},{"id":2571788,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T22:15:27.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":2690079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":2690079,"derivative":{"exercise_price":10.23,"expiration_date":"2031-09-09","underlying":"Class A Common Stock","underlying_shares":2690079},"source":{"system":"sec-edgar","filing":"0001213900-21-047756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000121390021047756/ownership.xml","form_type":"4"}},{"id":2629026,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T01:11:25.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":1921485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Business Combination Agreement, each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":1921485,"derivative":{"exercise_price":10.21,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":1921485},"source":{"system":"sec-edgar","filing":"0001209191-21-047510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000120919121047510/doc4.xml","form_type":"4"}},{"id":2629025,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T01:11:25.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":384297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Business Combination Agreement, each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, December 15, 2019, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":384297,"derivative":{"exercise_price":3.7,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":384297},"source":{"system":"sec-edgar","filing":"0001209191-21-047510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000120919121047510/doc4.xml","form_type":"4"}},{"id":2629024,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T01:11:25.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":174680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Business Combination Agreement, each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":174680,"derivative":{"exercise_price":3.88,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":174680},"source":{"system":"sec-edgar","filing":"0001209191-21-047510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000120919121047510/doc4.xml","form_type":"4"}},{"id":2629023,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T01:11:25.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":349360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Business Combination Agreement, each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 28, 2018, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":349360,"derivative":{"exercise_price":2.87,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":349360},"source":{"system":"sec-edgar","filing":"0001209191-21-047510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000120919121047510/doc4.xml","form_type":"4"}},{"id":2629022,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-21T01:11:25.000Z","date":"2021-07-16","kind":"other","acquired":true,"shares":7734689,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the \"Business Combination Agreement\"), by and among GX Acquisition Corp. (\"GX\"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. (\"Legacy Celularity\"), each share of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into the right to receive a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to \"Celularity Inc.\""}],"balance_after":7734689,"source":{"system":"sec-edgar","filing":"0001209191-21-047510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398815/000120919121047510/doc4.xml","form_type":"4"}},{"id":2723533,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Rights","published_at":"2021-05-07T22:42:58.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":2708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock right represents a contingent right to receive one share of CYRX common stock."}],"balance_after":2708,"derivative":{"exercise_date":"2022-04-30","expiration_date":"2022-04-30","underlying":"Common Stock","underlying_shares":2708},"source":{"system":"sec-edgar","filing":"0001104659-21-063251","document":"tm2115610d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465921063251/tm2115610d4_4.xml","form_type":"4"}},{"id":2723532,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-05-07T22:42:58.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":5416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021."}],"balance_after":5416,"derivative":{"exercise_price":56.57,"expiration_date":"2028-04-30","underlying":"Common Stock","underlying_shares":5416},"source":{"system":"sec-edgar","filing":"0001104659-21-063251","document":"tm2115610d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465921063251/tm2115610d4_4.xml","form_type":"4"}},{"id":3072676,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to purchase common stock","published_at":"2020-07-31T21:20:00.000Z","date":"2020-07-20","kind":"other","acquired":false,"shares":15300,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.57,"exercise_date":"2016-01-30","expiration_date":"2020-07-29","underlying":"Common Stock","underlying_shares":15300},"source":{"system":"sec-edgar","filing":"0001104659-20-089168","document":"tm2026274d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465920089168/tm2026274d2_4.xml","form_type":"4"}},{"id":3072675,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-31T21:20:00.000Z","date":"2020-07-20","kind":"other","acquired":true,"shares":15300,"price":3.57,"value":54621.0,"ownership":{"direct":true},"balance_after":30600,"source":{"system":"sec-edgar","filing":"0001104659-20-089168","document":"tm2026274d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465920089168/tm2026274d2_4.xml","form_type":"4"}},{"id":3161667,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2020-05-06T01:12:32.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of these options vest and become exercisable on the 1st of each month for twelve (12) months beginning on 06/01/2020."}],"balance_after":35000,"derivative":{"exercise_price":18.02,"expiration_date":"2030-05-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-20-057100","document":"tm2018763d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000110465920057100/tm2018763d5_4.xml","form_type":"4"}},{"id":3181550,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-06T21:13:09.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":3306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded to the reporting person under the registrant's 2012 Equity Incentive Plan and will vest immediately."}],"balance_after":119364,"source":{"system":"sec-edgar","filing":"0001213900-20-008713","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402479/000121390020008713/ownership.xml","form_type":"4"}},{"id":3540280,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-05-03T23:53:38.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month r the next twelve (12) months beginning on 05/02/2019."}],"balance_after":35000,"derivative":{"exercise_price":14.35,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-19-023717","document":"tv520658_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000114420419023717/tv520658_4.xml","form_type":"4"}},{"id":3667929,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-08T17:09:05.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":10955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded to the reporting person under the registrant's 2012 Equity Incentive Plan and will vest immediately."}],"balance_after":116058,"source":{"system":"sec-edgar","filing":"0001213900-19-001970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402479/000121390019001970/ownership.xml","form_type":"4"}},{"id":3924235,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-05-22T01:01:04.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12 of these options vest and become exercisable in equal monthly installments on the 17th of each month for the next twelve (12) months beginning on 06/17/2018. Options issued under the compensation plan for non-employee directors for services as director during the 2018/19 term."}],"balance_after":35000,"derivative":{"exercise_price":9.29,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-18-030145","document":"tv494662_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000114420418030145/tv494662_4.xml","form_type":"4"}},{"id":3924234,"issuer":{"id":5125,"kind":"organization","name":"Cryoport, Inc."},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-05-22T01:01:04.000Z","date":"2017-06-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of these options vested and became exercisable in equal monthly installments on the 23rd of each month for the next twelve (12) months beginning on 07/23/2017. Options issued under the compensation plan for non-employee directors for services as director during the 2017/18 term."}],"balance_after":35000,"derivative":{"exercise_price":4.8,"expiration_date":"2027-06-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-18-030145","document":"tv494662_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124524/000114420418030145/tv494662_4.xml","form_type":"4"}},{"id":4105317,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-05T16:05:11.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":7353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded to the reporting person under the registrant's 2012 Equity Incentive Plan and will vest immediately."}],"balance_after":105103,"source":{"system":"sec-edgar","filing":"0001213900-18-000171","document":"f4010318hariri_myos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402479/000121390018000171/f4010318hariri_myos.xml","form_type":"4"}},{"id":4509685,"issuer":{"id":94590,"kind":"organization","name":"MedAvail Holdings, Inc.","symbol":"MDVL"},"owners":[{"id":40616,"kind":"person","name":"Hariri Robert J","position":1,"cik":"0001398815","reported_name":"Hariri Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-30T16:32:24.000Z","date":"2016-12-28","kind":"grant","acquired":true,"shares":4386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded to the reporting person under the registrant's 2012 Equity Incentive Plan and will vest on January 1, 2017."}],"balance_after":97750,"source":{"system":"sec-edgar","filing":"0001213900-16-019817","document":"f4122816hariri_myosrens.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1402479/000121390016019817/f4122816hariri_myosrens.xml","form_type":"4"}}]}